Background. A clinical decision rule (CDR), combined with a negative D-dimer test, can safely rule out deep venous thrombosis (DVT) in primary care. This strategy is recommended by guidelines, yet uptake by GPs is low. Objective. To evaluate a multi-faceted implementation strategy aimed at increased use of the guideline recommended CDR plus D-dimer test in primary care patients with suspected DVT. Methods. This multi-faceted implementation strategy consisted of educational outreach visits, financial reimbursements and periodical newsletters. 217 Dutch GPs (implementation group) received this strategy and included patients. Effectiveness was measured through the following patient-level outcomes: (i) proportion of non-referred patients, (ii) proportion of missed DVT cases within this group and (iii) the proportion of patients in whom the guideline was applied incorrectly. Implementation outcomes ('acceptability', 'feasibility', 'fidelity' and 'sustainability') were assessed with an online questionnaire. Patient-level outcomes were compared with those of patients included by 450 GPs, uninformed about the study's purposes providing information about usual care. Results. 336 (54%) of 619 analyzable implementation group patients were not referred, missing 6 [1.8% (95% confidence interval 0.7% to 3.9%)] DVT cases. Incorrect guideline use was observed in 199 patients (32%). Self-reported acceptability, feasibility and expected sustainability were high. Guideline use increased from 42% to an expected continuation of use of 91%. Only 32 usual care GPs included 62 patients, making formal comparison unreliable. Conclusions. This multi-faceted implementation strategy safely reduced patient referral to secondary care, despite frequently incorrect application of the guideline and resulted in high acceptability, feasibility and expected sustainability.
Introduction
Patients with leg complaints, such as pain, redness or swelling of the calf, commonly first consult their GP. Timely diagnosis of deep venous thrombosis (DVT; a clot in the proximal deep veins of the leg) is important, as a missed event may result in potentially fatal pulmonary embolism (1) . Given that signs and symptoms are relatively non-specific, GPs tended to refer almost every suspected patient for compression ultrasonography (CUS), the reference test that is conducted in secondary care. This is inconvenient and relatively costly for patients (2) , especially since the prevalence of DVT in those suspected is low, ranging from 13% to 22% (3) (4) (5) (6) .
To reduce this high number of referrals for CUS, a clinical decision rule (CDR) for ruling out DVT in primary care patients with clinically suspected DVT was developed (Table 1) (4) . This rule differs from the well-known Wells rule (7), since research in general practice demonstrated that use of the Wells score combined with D-dimer (a fibrin degradation product) testing was neither safe nor efficient in primary care patients (8) . Both the following external validation study (6) and management study (3) consistently demonstrated that by using this CDR for primary care patients combined with a negative D-dimer test referral for CUS can indeed be withheld safely in nearly half of all suspected patients, at the cost of missing about 1-2% of DVT events in those not referred (3, 4, 6) . This approach has been demonstrated to be safe in various subgroups of patients with suspected DVT and yielded superior cost-effectiveness compared to usual care (9) (10) (11) . Not surprisingly, the use of this CDR, combined with D-dimer testing to enhance decision making in primary care patients with suspected DVT, has been advocated by the formal primary care guideline in The Netherlands since 2008 (12) .
However, the mere existence of a guideline does not guarantee its use. Evidence shows that passive implementation of clinical guidelines often is not sufficient, even if guideline use has been proven effective on the structure, process and outcomes of patient care (13) (14) (15) (16) (17) . Indeed it turned out, that a year after the guideline's publication only 46% of the GPs actually used it (data available upon request). This underuse potentially leads to mismanagement of patients with suspected DVT and unnecessary referral to secondary care (18) . For successful implementation of a guideline, focus on specific barriers and facilitators for the use of that guideline is required (15) , but evidence on effective implementation strategies for DVT management in primary care is scarce. Accordingly, we embarked upon the ADVICE study, with the following objective: to evaluate a multi-faceted implementation strategy aimed at increasing the use of the guideline recommended CDR plus D-dimer test in patients with suspected DVT in primary care. Furthermore, we tried to identify barriers and facilitators for use of this guideline.
Methods
Reporting of the implementation strategy is based on the SQUIRE 2.0 recommendations for reporting health care improvement studies (19) .
Implementation strategy
This study was conducted in the northern and middle part of The Netherlands from January 2013 (5 years after the guideline's publication), until June 2015. The multi-faceted implementation strategy consisted of a combination of three elements: educational outreach visits, guaranteed financial reimbursement and periodical newsletters (13) (14) (15) (16) (17) . The most important aspect was the educational outreach visit, as this is one of the most effective individual strategies when integrating a new clinical guideline (11, 13) . These visits were performed by one experienced team member (RO), who visited small groups of approximately 10-20 GPs working together in a certain designated area. These visits were focused on how to use the 2008 guideline for managing DVT in primary care and educational aspects were tailored to local preferences of and questions from the participating GPs. Secondly, the health care insurance companies agreed to provide participating GPs with a guaranteed financial reimbursement. This reimbursement did not depend on the actual number of suspected patients included in this study, but rather on the size of the total patient population registered with each participating GP (roughly around 1000 euro per practice). Finally, all participating GPs received four newsletters, sent approximately every 4 months by e-mail, explaining and emphasizing guideline use. In total, six larger clusters of in total 217 GPs participated in this study and received this implementation strategy (implementation group). The implementation strategy was completed in 2013, whereas the effect of the strategy was studied mainly during 2014 and the first half year of 2015. During this time, GPs were asked to register all patients with a clinically suspected DVT on a paper case-record form (CRF), which consisted of a description of the CDR, an instruction on how to calculate the CDR score and subsequently when to perform a D-dimer test in order to make a referral decision. GPs were asked to indicate whether a patient was referred. The outcome (DVT presence yes or no) of this referral decision was collected after a 3-month follow-up.
Patient-level outcomes
The evaluation of this multi-faceted implementation strategy consisted of an assessment of the following three patient-level outcomes: (i) the proportion of patients referred to secondary care ('efficiency'), (ii) the proportion of missed DVT cases in those not referred during 3-month follow-up ('safety') and (iii) the proportion of patients in whom the guideline was applied incorrectly. The first outcome was directly extracted from the CRFs. The proportion of missed DVT cases in those actually not referred was determined by 3-month follow-up, to identify potentially missed DVT cases. If during these 3 months of follow-up, no venous thromboembolism (VTE: DVT or pulmonary embolism) was diagnosed, DVT was considered absent during the time of initial suspicion, in accordance with previous studies done in this field. Finally, we documented in which patients the guideline was incorrectly used. This could refer to (i) including patients for whom the guideline was not developed [suspicion of pulmonary embolism (PE) or upper extremity DVT, pregnant women or during puerperium, patients already taking anticoagulants or children (age under 18 years)], (ii) calculation errors made by the GP when adding CDR points, (iii) inappropriate use of the D-dimer test (performing a D-dimer in a patient with a high CDR score or not performing the test in a patient with a low score) or (iv) deviate from the proposed referral recommendation (not refer a highrisk patient or refer a low-risk patient).
Implementation outcomes
Using the definition provided by Proctor and co-workers, we evaluated our implementation strategy on four distinct so-called In patients with a score ≤ 3 a D-dimer test is performed. If negative, the patient is not referred and DVT is considered excluded.
A patient with a positive D-dimer test or a score ≥ 4 is referred to secondary care for compression ultrasonography. implementation outcomes: 'acceptability', 'feasibility', 'fidelity' and 'sustainability' (20) . Hereto, we sent an online questionnaire to the implementation GPs at the end of 2014. This questionnaire was constructed within our department, after interviewing five GPs (not participating in the ADVICE study) on relevant content. The questionnaire also included several questions about perceived barriers and facilitators for use of the guideline and measures for self-reported use, both prior to and after having received the implementation strategy.
Contextual background: usual care (usual care group)
In order to make a comparison on patient level with usual care, we aimed to include patients via GPs from four clusters of approximately 450 GPs who had not received any aspect of our implementation strategy and therefore were uninformed about our study's purposes. Hereto, we used a separate CRF. To prevent contamination of our implementation strategy, we deliberately refrained from explaining the true purpose of sending these CRFs, but rather informed them that we wanted to get insight in their current referral patterns in patients with suspected DVT. Hence, this CRF did not include a detailed description of the CDR, although all items were available in order to calculate the CDR score post hoc by the researchers. Similar to the implementation CRF, GPs were asked to indicate if a suspected patient was referred and information about the final diagnosis was collected after a 3-month follow-up.
Analysis
All analyses were performed with IBM SPSS Statistics version 21.0 or PASS Version 2008.0.0.35_1. We quantified the proportion of non-referred patients and the proportion of patients with a missed DVT during 3-month follow-up in those initially not referred, with their 95% confidence intervals (CIs).
Ethical considerations
The medical ethics committee of the University Medical Center Utrecht judged this study exempt for review according to Dutch law, given that only guideline use was evaluated. A waiver for informed consent was provided, as patient information for data collection and analyses was encrypted for the researchers.
Results

Implementation group: patient-level outcomes
Patients were included by GPs in the implementation group between October 2013 and June 2015. Patient characteristics are shown in Table 2 . 135 of the 217 GPs (62%) in the implementation group included 625 patients in this study. There were no patients with missing CDR data. Six patients (<1%) were lost to follow-up and therefore excluded from further analyses.
Of the 619 remaining patients, 335 were not referred (54%). During follow-up (at least 3 months in 97% of the non-referred patients), six patients were nevertheless diagnosed with VTE, resulting in a proportion of missed DVT cases of 1.8% (95% CI 0.7% to 3.9%; Table 3 ).
However, in three of these six patients, the choice for nonreferral was based on shared decision making with the patient dictated by individual circumstances (only supportive care in all three cases and a clinical diagnosis of DVT). As such, the clinical consequences directly attributable to the actual non-referral recommendation of the guideline are three truly missed DVT cases in those not referred, i.e. 0.9% (95% CI 0.2% to 2.6%). In a substantial number of included patients (199; 32%), incorrect guideline use was observed (Table 4 ). In at least 50 patients, this was deliberate and indicated as such on the CRF. The number of DVT cases in those not referred within this group was 3. These patients were deliberately not referred, as mentioned earlier. Excluding these 199 patients from the analyses yielded similar inferences, 242 non-referred patients (of 420 patients; 58%) with 3 missed DVT cases in those not referred (1.2%; 95% CI 0.2% to 3.5%).
Implementation group: implementation outcomes
Implementation outcomes were measured by means of an online questionnaire. 10 of the 217 implementation group GPs did not receive this questionnaire for a variety of reasons (GP retired during study, serious illness of GP, etc.). A total of 89 GPs responded after two reminders (43%). Self-reported use of the guideline increased from 42% before the start of the study to 91% of the GPs stating that they intended to continue using the guideline most of the times or always after the study's termination (expected sustainability; P value < 0.005). The implementation outcomes 'acceptability', 'feasibility', 'fidelity' and 'expected sustainability' are summarized in Table 5 . The acceptability of the guideline was found to be high, with good feasibility in daily clinical practice, except outside office hours. In terms of fidelity of the implementation strategy, the educational outreach visit (as part of our multi-faceted strategy) was received by most GPs. A substantial group of GPs stated that they had not received the financial reimbursement.
The most often mentioned barriers for guideline use included higher age or comorbidity of the patient and lack of time. Perceived support of the guideline in the diagnostic process and availability of a point-of-care D-dimer test in the GP's practice were the most frequently mentioned facilitators (Table 5 ).
Usual care group: patient-level outcomes
32 of approximately 450 GPs (7%) in the usual care group included only 70 patients. Eight patients were excluded from the analysis due to missing follow-up data (11%). Of the 62 analysable patients left, 31 were not referred to secondary care (50%) and no DVT cases were missed in this group of non-referred patients during 3-month follow-up (0%, 95% CI 0 to 11.2%; Table 3 ).
Discussion
This study evaluated the patient and implementation outcomes of a multi-faceted implementation strategy, aimed at increasing guideline use in patients with suspected DVT in primary care. Within the implementation group, we observed that referral was no longer deemed necessary in more than half of all suspected patients. This results in a reduction in referrals of more than 50%, at the cost of missing less than 2% of DVT cases in those not referred. This is consistent with our previous studies that were conducted in a much more controlled research setting (3, 4, 6) and despite the incorrect guideline use observed in about one-third of all suspected patients. The reproducibility of these results with a much more diverse group of GPs, without an obligatory referral or follow-up visit incorporated in the study design as a safety net for those not referred (as was demanded in our previous studies' protocols), further strengthens the recommendation for the use of this CDR and D-dimer test in order to safely rule out DVT in a general population of adult primary care patients. Furthermore, compared to existing literature on implementation research, the results of the questionnaire filled out by implementation GPs showed high acceptability and feasibility of this guideline (21) . Largely in accordance with existing literature (13) (14) (15) (16) (17) , the educational outreach visits (as part of our multi-faceted strategy) were reviewed most encouraging by GPs. Self-reported expected sustainability (expectation of continuing usage of this guideline after the study's termination) was remarkably high. The two most frequently perceived barriers, patient characteristics and lack of time, are also in accordance with literature (22) .
Limitations
Although we believe our results are encouraging, showing that this multi-faceted implementation strategy impacts both patient-level and implementation outcomes positively, some aspects deserve further elaboration for full appreciation of our study's findings.
First of all, the questionnaire was not validated before sending and the response (43%) may be considered relatively low. However, this percentage is not uncommon in primary care-based surveys (23) . Besides, the characteristics of the respondents corresponded reasonably well with the characteristics of Dutch GPs on average (Supplementary Data Table S1 ). Therefore, we believe that we can make inferences from these results.
Secondly, both the number of participating GPs within the usual care group and number of included patients by those participating were very low. It is possible that the patients included by the usual care group GPs are a different selection from those included by the implementation group GPs, resulting in selection bias. This low Total number of patients for whom this diagnostic strategy should not have been used, e.g. in pregnant women or for a suspicion of pulmonary embolism instead of DVT. Of note, a patient can only be counted once; if a patient was both pregnant and suspected of pulmonary embolism, she counts as 1. Three patients were deliberately not referred (shared decision making). Therefore, the number of patients with a truly missed VTE directly attributable to the non-referral recommendation of the guideline is 3 (0.9%; 95% CI 0.2-2.6%).
inclusion is most probably the result of our design, by which we tried to prevent a dilution of the effect of our implementation strategy resulting from contamination of the usual care group. Had we used a cluster randomized trial, this contamination would surely have happened. Informing usual care GPs about our study aims (implementation of a guideline already published in 2008 in order to increase its use) would have led to an increased uptake of the guideline recommendations by this group, therefore not representing usual care. But despite our design, contamination still happened. One cluster of GPs in the usual care group organized an educational session on diagnosing DVT in primary care and managed to get a small reimbursement for participating GPs as well. As such, this cluster can be viewed as having also received at least part of our implementation strategy and therefore being contaminated after all. These GPs included the vast majority of usual care patients (19 GPs included 33 patients). Thus, although essentially our efforts to provide an uncontaminated contextual background on how a clinical suspicion of DVT is managed without our implementation strategy failed, we still choose to report these findings in our article. In fact, these should be regarded as the consequence of performing real-life implementation research in a setting where the formal guideline is already published and considered to be standard of care, but is not adhered to in practice. On forehand, we already anticipated a lower number of inclusions per GP in the usual care group. We therefore sent the usual care CRF to almost twice as many GPs. Nevertheless, we were confronted with a very low number of inclusions. We believe though that this in itself is already an important finding and lesson from this study, underlying the need for active instead of passive implementation. Still, a formal comparison on this level should be made with great caution.
Implications for research and practice
First, and foremost, our study demonstrates a high degree of acceptability and feasibility for using the CDR plus D-dimer test to rule out DVT in primary care. This shows no need for a change in diagnostic strategy. The finding that in at least half of all suspected patients referral for ultrasonography can be safely withheld strengthens this and confirms our previous studies performed in much more controlled research settings. Educational outreach visits were reviewed most encouraging and had highest fidelity. Therefore, these should in any case be part of a further, nationwide implementation strategy, although possibly more difficult to apply this on a large scale. During these sessions, further emphasis should be on the perceived facilitators and how to correctly use the guideline, since this was found to be either inappropriate (in the wrong patient) or incorrect (calculation errors, unjustified use of a D-dimer test, not following guideline recommendations on referral) in a large number of patients, despite the (written and oral) instructions the implementation GPs received during this study. Although we know from the CRFs that this was done deliberately in a subset of patients (at least 50 of 199), this could have dangerous consequences. Yet, it did not result in a higher number of missed DVT cases in this study. The incorrect use may be a consequence of the fact that DVT is a relatively rare disorder in primary care (incidence 0.5-1.5 per 1000 patients) and therefore infrequently encountered by GPs (12) . Incorrect guideline use may be prevented by the development of a computerized decision support tool within the electronic patient record guiding the GP through the different steps of the diagnostic strategy. Further research is needed to verify this hypothesis. One important perceived barrier for use of the CDR plus D-dimer was the patient's old age or multi-morbidity. This group of frail elderly patients is subject for further and currently on-going research (24, 25) .
Conclusion
This multi-faceted implementation strategy aimed at increasing use of the guideline recommended CDR and D-dimer test in primary care patients with clinically suspected DVT safely reduced referrals and resulted in high acceptability, feasibility and suspected sustainability.
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